TransMedics Group Inc (TMDX) Stock Price Today
Key Stats
- $2.91BMarket Cap
- 622,596Volume
- HealthSector
- $150.4252W High
- $61.9952W Low
- 23 DaysTypical Hold Time
- $3.30BEnterprise Value
- -Div Yield
- 78% Sell | 22% BuyTrading Activity
Track TransMedics Group Inc (TMDX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TransMedics Group Inc has traded between a low of $61.99 and a high of $150.42, highlighting its annual price range. Buy and sell TransMedics Group Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Most Recent News
QuinStreet CFO Gregory Wong sells 11,704 shares, signaling possible portfolio adjustment.
Gregory Wong, the Chief Financial Officer of QuinStreet, has sold 11,704 shares of the company. This transaction may indicate a personal portfolio adjustment or a response to market conditions. Investors might watch for further insider trading activi...

Masonglory, INLIF, and Apimeds stocks surge on strategic deals and strong results
Masonglory Limited's shares soared over 300% following its share swap deal to acquire a 20% stake in an Austrian construction firm, expanding its business scope. INLIF Limited gained about 74% after reporting strong first-half fiscal 2026 results wit...

Class action launched over alleged misleading info by BlackRock affecting mutual fund investors
The Rosen Law Firm is investigating claims that BlackRock, Inc. provided misleading business information to investors in its mutual funds. Investors who purchased BlackRock mutual funds may be eligible for compensation through a class action lawsuit ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.